دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Clinicopathologic Conference: A 70-Year-Old Male With Hypertensive Emergency
Saika Sharmeen,Michael Arcomano,John Langenberg,Hiroshi Kato,Fatme Allam
doi : 10.1002/acr.24164
Volume 73, Issue 12 p. 1701-1707
Clinicopathologic Conference: Straight From the Cradle: A Patient With Early-Onset Polyautoimmunity and Recurrent Infections
Samuel Gaine,Diana M. Bongiorno,Sara Baig,Andrea Fava,George Stojan
doi : 10.1002/acr.24624
Volume 73, Issue 12 p. 1708-1713
Variation in Treatment of Children Hospitalized With New-Onset Systemic Juvenile Idiopathic Arthritis in the US
Rosemary G. Peterson,Rui Xiao,Karen E. James,Hannah Katcoff,Brian T. Fisher,Pamela F. Weiss
doi : 10.1002/acr.24417
Volume 73, Issue 12 p. 1714-1721
Increasing evidence supports the conclusion that early initiation of biologics may dramatically improve disease course and reduce glucocorticoid exposure for children with systemic juvenile idiopathic arthritis (JIA). The present study was undertaken to characterize variation in the use of first-line biologic and glucocorticoid therapy and to identify drivers of variation in children hospitalized with new-onset systemic JIA.
Determinants of Discordance Between Criteria for Inactive Disease and Low Disease Activity in Juvenile Idiopathic Arthritis
Gabriella Giancane,Chiara Campone,Maria Francesca Gicchino,Alessandra Alongi,Cecilia Bava,Silvia Rosina,Yaryna Boyko,Neil Martin,Yasser El Miedany,Miroslav Harjacek,Soad Hashad,Maka Ioseliani,Ruben Burgos-Vargas,Rik Joos,Christiaan Scott,Mejbri Manel,Zoilo Morel Ayala,Maria Ekelund,Safiya Al-Abrawi,Maya-Feriel Aiche,Ximena Norambuena,Jose Antonio Melo-Gomes,Nicolino Ruperto,Alessandro Consolaro,Angelo Ravelli,for the Paediatric Rheumatology International Trials Organisation
doi : 10.1002/acr.24415
Volume 73, Issue 12 p. 1722-1729
To assess concordance among criteria for inactive disease (ID) and low disease activity (LDA) in juvenile idiopathic arthritis (JIA) and to seek factors driving discordance.
Time to First Completed Visit and Health Care Utilization Among Young Adults Transferring From Pediatric to Adult Rheumatologic Care in a Safety-Net Hospital
Nicole Bitencourt,Bonnie L. Bermas,Una E. Makris,Tracey Wright,Joan Reisch,E. Blair Solow
doi : 10.1002/acr.24409
Volume 73, Issue 12 p. 1730-1738
The transfer from pediatric to adult care for young adults is a vulnerable period. Our objectives were to quantify the time between the final pediatric and the first adult visit and to evaluate unscheduled utilization in care and progression to end-stage renal disease (ESRD) or death.
Down Syndrome–Associated Arthritis Cohort in the New Childhood Arthritis and Rheumatology Research Alliance Registry: Clinical Characteristics, Treatment, and Outcomes
Jordan T. Jones,Chelsey Smith,Mara L. Becker,Daniel Lovell,for the CARRA Registry Investigators
doi : 10.1002/acr.24418
Volume 73, Issue 12 p. 1739-1745
Down syndrome–associated arthritis (DA) is underrecognized, and current therapies used for juvenile idiopathic arthritis (JIA) appear to be poorly tolerated and less effective in patients with DA. The objective of this study was to characterize clinical manifestations and therapeutic preferences in DA compared to JIA, using the new Childhood Arthritis and Rheumatology Research Alliance (nCARRA) registry.
Guidance for Implementing Best Practice Therapeutic Exercise for Patients With Knee and Hip Osteoarthritis: What Does the Current Evidence Base Tell Us?
Melanie A. Holden,Kate Button,Natalie J. Collins,Yves Henrotin,Rana S. Hinman,Jesper B. Larsen,Ben Metcalf,Hiral Master,Søren T. Skou,Louise M. Thoma,Elizabeth Wellsandt,Daniel K. White,Kim Bennell
doi : 10.1002/acr.24434
Volume 73, Issue 12 p. 1746-1753
Therapeutic exercise is a recommended first-line treatment for patients with knee and hip osteoarthritis (OA); however, there is little specific advice or practical resources to guide clinicians in its implementation. As the first in a series of projects by the Osteoarthritis Research Society International Rehabilitation Discussion Group to address this gap, we aim in this narrative review to synthesize current literature informing the implementation of therapeutic exercise for patients with knee and hip OA, focusing on evidence from systematic reviews and randomized controlled trials. Therapeutic exercise is safe for patients with knee and hip OA. Numerous types of therapeutic exercise (including aerobic, strengthening, neuromuscular, mind-body exercise) may be utilized at varying doses and in different settings to improve pain and function. Benefits from therapeutic exercise appear greater when dosage recommendations from general exercise guidelines for healthy adults are met. However, interim therapeutic exercise goals may also be useful, given that many barriers to achieving these dosages exist among this patient group. Theoretically-informed strategies to improve adherence to therapeutic exercise, such as patient education, goal-setting, monitoring, and feedback, may help maintain participation and optimize clinical benefits over the longer term. Sedentary behavior is also a risk factor for disability and lower quality of life in patients with knee and hip OA, although limited evidence exists regarding how best to reduce this behavior. Current evidence can be used to inform how to implement best practice therapeutic exercise at a sufficient and appropriate dose for patients with knee and hip OA.
Limiting the Risk of Osteoarthritis After Anterior Cruciate Ligament Injury: Are Health Care Providers Missing the Opportunity to Intervene?
Aileen M. Davis,Jas Chahal,Rosalind Wong,Krista Steinhart,Tim Dwyer,Linda Li,Paul Marks,Laura Cruz,Nathan Urquhart,Janie Astephen Wilson,David Cudmore,Laura Nimmon,Darrell Ogilvie-Harris
doi : 10.1002/acr.24419
Volume 73, Issue 12 p. 1754-1762
To understand what sports orthopedic surgeons (OS), primary care physicians (PCPs) with sports medicine training, and physical therapists (PTs) managing nonelite athletes with anterior cruciate ligament (ACL) injury tell their patients about their osteoarthritis (OA) risk.
How Foot Progression Angle Affects Knee Adduction Moment and Angular Impulse in Patients With and Without Medial Knee Osteoarthritis: A Meta-Analysis
Sizhong Wang,Shiwei Mo,Raymond C. K. Chung,Peter B. Shull,Daniel C. Ribeiro,Roy T. H. Cheung
doi : 10.1002/acr.24420
Volume 73, Issue 12 p. 1763-1776
To investigate effects of foot progression angle (FPA) modification on the first and second peaks of external knee adduction moment (EKAM) and knee adduction angular impulse (KAAI) in individuals with and without medial knee osteoarthritis (OA) during level walking.
Examining the Association of Knee Pain With Modifiable Cardiometabolic Risk Factors
Daniel A. Charen,David Solomon,Nicole Zubizarreta,Jashvant Poeran,Alexis C. Colvin
doi : 10.1002/acr.24423
Volume 73, Issue 12 p. 1777-1783
A well-established link exists between obesity and knee osteoarthritis, and recent research has implicated diabetes mellitus as a potential cause of cartilage degeneration. The objective of this study was to use the National Health and Nutrition Examination Survey (NHANES) database to examine the association between knee pain and various metabolic factors.
Foot Osteoarthritis Frequency and Associated Factors in a Community-Based Cross-Sectional Study of White and African American Adults
Portia Flowers,Amanda E. Nelson,Marian T. Hannan,Howard J. Hillstrom,Jordan B. Renner,Joanne M. Jordan,Yvonne M. Golightly
doi : 10.1002/acr.24427
Volume 73, Issue 12 p. 1784-1788
Few studies have explored foot osteoarthritis (OA) in the general population. The purpose of this study was to determine the frequency of foot OA and identify associated factors in a cross-sectional analysis of a large community-based cohort.
Cancer Risk in a Large Inception Systemic Lupus Erythematosus Cohort: Effects of Demographic Characteristics, Smoking, and Medications
Sasha Bernatsky,Rosalind Ramsey-Goldman,Murray B. Urowitz,John G. Hanly,Caroline Gordon,Michelle A. Petri,Ellen M. Ginzler,Daniel J. Wallace,Sang-Cheol Bae,Juanita Romero-Diaz,Mary Anne Dooley,Christine A. Peschken,David A. Isenberg,Anisur Rahman,Susan Manzi,Søren Jacobsen,S. Sam Lim,Ronald van Vollenhoven,Ola Nived,Diane L. Kamen,Cynthia Aranow,Guillermo Ruiz-Irastorza,Jorge Sánchez-Guerrero,Dafna D. Gladman,Paul R. Fortin,Graciela S. Alarcón,Joan T. Merrill,Kenneth C. Kalunian,Manuel Ramos-Casals,Kristjan Steinsson,Asad Zoma,Anca Askanase,Munther A. Khamashta,Ian Bruce,Murat Inanc,Ann E. Clarke
doi : 10.1002/acr.24425
Volume 73, Issue 12 p. 1789-1795
To assess cancer risk factors in incident systemic lupus erythematosus (SLE).
Cervical Cancer Screening in Women With Systemic Lupus Erythematosus
Sebastian Bruera,Xiudong Lei,Richard Zogala,Xerxes Pundole,Hui Zhao,Sharon H. Giordano,Jessica P. Hwang,J. Alejandro Rauh-Hain,Maria E. Suarez-Almazor
doi : 10.1002/acr.24414
Volume 73, Issue 12 p. 1796-1803
To determine rates of cervical cancer screening and associated abnormal results in women with systemic lupus erythematosus (SLE).
Impact of the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus in a Multicenter Cohort Study of 133 Women With Undifferentiated Connective Tissue Disease
Massimo Radin,Karen Schreiber,Irene Cecchi,Alessandra Bortoluzzi,Francesca Crisafulli,Cristiano M. de Freitas,Beatrice Bacco,Elena Rubini,Silvia G. Foddai,Melissa Padovan,Silvia Gallo Cassarino,Franco Franceschini,Danieli Andrade,Chiara Benedetto,Marcello Govoni,Tiziana Bertero,Luca Marozio,Dario Roccatello,Laura Andreoli,Savino Sciascia
doi : 10.1002/acr.24391
Volume 73, Issue 12 p. 1804-1808
We aimed to investigate the impact of applying the 2019 European Alliance of Associations for Rheumatology (EULAR)/American College of Rheumatology (ACR) classification criteria for systemic lupus erythematosus (SLE) in a previously described cohort of women with undifferentiated connective tissue disease (UCTD).
Adaptation of American College of Rheumatology Rheumatoid Arthritis Disease Activity and Functional Status Measures for Telehealth Visits
Bryant R. England,Claire E. H. Barber,Martin Bergman,Veena K. Ranganath,Lisa G. Suter,Kaleb Michaud
doi : 10.1002/acr.24429
Volume 73, Issue 12 p. 1809-1814
To provide guidance on the implementation of recommended American College of Rheumatology (ACR) rheumatoid arthritis (RA) disease activity and functional status assessment measures in telehealth settings.
Do Obesity and Overweight Influence Disease Activity Measures in Axial Spondyloarthritis? A Systematic Review and Meta-Analysis
Augusta Ortolan,Mariagrazia Lorenzin,Mara Felicetti,Roberta Ramonda
doi : 10.1002/acr.24416
Volume 73, Issue 12 p. 1815-1825
The aim of our systematic review and meta-analysis was to investigate whether overweight/obesity are associated with higher disease activity measures in patients with axial spondyloarthritis (SpA).
Patient-Reported Impact of Axial Spondyloarthritis on Working Life: Results From the European Map of Axial Spondyloarthritis Survey
Marco Garrido-Cumbrera,Christine Bundy,Victoria Navarro-Compán,Souzi Makri,Sergio Sanz-Gómez,Laura Christen,Raj Mahapatra,Carlos J. Delgado-Domínguez,Denis Poddubnyy
doi : 10.1002/acr.24426
Volume 73, Issue 12 p. 1826-1833
To evaluate work-related issues (WRIs) and their determinants in patients with axial spondyloarthritis (SpA) across Europe.
Impact of Disease Activity on Physical Activity in Patients With Psoriatic Arthritis
María Vanesa Hernández-Hernández,Hiurma Sánchez-Pérez,Cristina Luna-Gómez,Iván Ferraz-Amaro,Federico Díaz-González
doi : 10.1002/acr.24422
Volume 73, Issue 12 p. 1834-1844
The purpose of this study was to compare physical activity (PA) in a group of patients with psoriatic arthritis (PsA) versus healthy controls and to determine whether the mobility of these patients is affected by disease activity.
Factors Influencing Patient Decision-Making Concerning Treatment Escalation in Raynaud’s Phenomenon Secondary to Systemic Sclerosis
Michael Hughes,Suiyuan Huang,John D. Pauling,Maya Sabbagh,Dinesh Khanna
doi : 10.1002/acr.24710
Volume 73, Issue 12 p. 1845-1852
To explore patient priorities and ranking of factors influencing patient decision-making concerning treatment escalation in the management of Raynaud’s phenomenon (RP) secondary to systemic sclerosis (SSc).
Mortality Among Patients With Polymyalgia Rheumatica: A Retrospective Cohort Study
Richard Partington,Sara Muller,Christian D. Mallen,Alyshah Abdul Sultan,Toby Helliwell
doi : 10.1002/acr.24403
Volume 73, Issue 12 p. 1853-1857
To determine whether a diagnosis of polymyalgia rheumatica (PMR) is associated with premature mortality.
Trajectories of structural disease progression in knee osteoarthritis: comment on the article by Collins et al
Daniel L. Riddle,Levent Dumenci
doi : 10.1002/acr.24389
Volume 73, Issue 12 p. 1858-1858
Reply
Jamie E. Collins PhD,Tuhina Neogi MD, PhD,Elena Losina PhD
doi : 10.1002/acr.24388
Volume 73, Issue 12 p. 1859-1859
